French biotech firm develops long-lasting flu vaccine

The formula has been successful in animal trials, and is now being tested on humans | Photo source Pixabay Healthcare & Wellbeing Osivax is seeking to prevent influenza outbreaks by targeting a specific part of the virus Facebook Twitter Tumblr Linked In Download PDF Takeaway: Influenza kills about 290,000 to 650,000 people a year. Osivax…

Biogen Hedged Its Bet and Won Big

The biotech had $4.3 billion in sales at risk. Sometimes a drugmaker’s best move isn’t developing a new drug but protecting sales of an established one. Sales of Biogen’s (NASDAQ:BIIB) top-selling multiple sclerosis drug Tecfidera brought in almost $4.3 billion last year, and sales are on pace to be even higher this year. Much of…

3 Top Biotech Stocks to Buy Right Now

These three biotech stocks might be outstanding buys right now. George Budwell, Keith Speights, and Todd Campbell Biotech stocks can be a risky proposition heading into an election year. These equities, after all, have proven to be extremely sensitive to the heated political rhetoric surrounding prescription drug prices in the United States. With this political…

Exelixis Hits Blockbuster Status

The biotech needed help from some friends to get there. Brian Orelli Aug 5, 2019 at 10:00AM Health Care Sales of Exelixis’ (NASDAQ:EXEL) cabozantinib franchise, which includes Cabometyx for kidney and liver cancers and Cometriq for thyroid cancer, broke $250 million globally in the second quarter, making the drug a blockbuster, typically defined as $1…

Little room for SC/ST scientists in biotech bodies

Close-up of a hand holding a chemistry test-tube with a chemical solution in a bio-chemistry DNA genetic research laboratory, GMO, human, animal, plants genetics research.   | Photo Credit: YinYang more-in RTI enquiry reveals poor representation Scientists from Scheduled Castes (SC) and Scheduled Tribes (ST) are grossly under-represented in scientific institutions funded by the Department…

Why Anika Therapeutics Stock Crushed It Today

Better-than-expected Q2 earnings results spurred investors’ interest in the small biotech. What happened Shares of Anika Therapeutics (NASDAQ:ANIK) were soaring 27.8% higher as of 3:07 p.m. EDT on Thursday. The biotech, which focuses primarily on pain management, tissue regeneration, and wound care, announced positive second-quarter results after the market closed on Wednesday. Anika’s revenue and earnings…

Is Viking Therapeutics a Buy?

What you need to know about this high-risk, high-reward biotech stock. Keith Speights Aug 11, 2019 at 9:15AM Health Care Nearly a year ago, Viking Therapeutics (NASDAQ:VKTX) became the darling of biotech investors. Shares skyrocketed in September 2018, after Viking announced positive results from a phase 2 clinical study of experimental drug VK2809.  Since then,…

This Is What Your Body Looks Like On A.I.

Science has revealed a multitude of ways evolution has shaped the processing of visual information within the animal kingdom. What we see as human beings varies significantly from the world insects, reptiles, and even other mammals experience. But what would an artificial intelligence see? Italian design studio Ultravioletto set out to answer this very question,…

Google DeepMind’s AI could give doctors a head start on saving lives, study says – CNET

Acute kidney injury causes around 500,000 deaths annually in the US. Roy Scott/Getty Images Artificial intelligence is frequently heralded as the future solution to many of the world’s biggest problems, and for many experts developing the technology, health comes top of the list. London-based DeepMind, owned by Google parent company Alphabet, is working on a…